After years of alarming increases in opioid overdose deaths, the U.S. finally saw a 1-year decline from 84,000 to 81,000 in ...

WASHINGTON — The Biden administration announced last Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to anti-obesity medications to reduce their weight over the ...

Using significantly higher doses of vitamin D than recommended for five years did not affect the incidence of type 2 diabetes in elderly men and women, according to a new study from the University of ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Shares of Telomir Pharmaceuticals climbed up 20% to $5.10 after the company said it saw positive pre-clinical results confirming the efficacy of its licensed molecule Telomir-1 in reversing several ...

More than half of all US adults are eligible for semaglutide therapy, according to a research letter published online.

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

Diabetes is very common. The Centers for Disease Control and Prevention (CDC) notes that 38.4 million people in the United ...

A systematic review reveals chronic pulmonary aspergillosis mortality is driven by age and underlying conditions, ...

The eyes serve as more than just organs of sight—they act as vital indicators of overall health. Medical professionals ...

Olufemi Fasanmade advised Nigerians with diabetes to be wary of unregistered medications, as they can increase the risk of ...